Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Kidney Int. 2019 Aug 16;96(6):1332–1345. doi: 10.1016/j.kint.2019.07.017

Figure 11: Pre-miR-146b treatment of NRK-49F cells may blunt expression of pro-fibrotic markers.

Figure 11:

qRT-PCR analysis of (A) miR-146b-5p abundance, (B) the mesenchymal marker Vim and the pro-fibrotic markers (C) Col1a1, and (D) Fn1 from NRK-49F cells treated with pre-miR-146b. All data presented as mean ± SEM, n = 6/group; * p<0.05 vs. control within group; # p<0.05 vs. TGF-β only, within group; ‡ p<0.05 vs. β-E2 only, within group; & p<0.05 pre-miR-146b vs. anti-SCR between indicated groups.